close

Enter

Log in using OpenID

Gastric and Esophageal Cancer Drugs Market - Industry Growth, and Analysis 2018-2026

embed
Increasing number of cancer drugs in pipeline studies and rising involvement of key players for development of cancer treatment are expected to propel gastric and esophageal cancer drugs market growth.
Gastric and Esophageal Cancer Drugs Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND
OPPORTUNITY ANALYSIS, 2018-2026
REPORT DESCRIPTION
Gastric and Esophageal Cancer Drugs Market – Overview
Increasing number of cancer drugs in pipeline studies and rising involvement of key players for development of
cancer treatment are expected to propel gastric and esophageal cancer drugs market growth. For instance, in April
2016, Centre Hospitalier Universitaire de Besancon, initiated Phase 1 and Phase 2 clinical trial for Carboplatin to
determine the maximum tolerated dose (MTD) and recommended doses for phase II (RP2D) by considering the
treatment scheme of Dutch study for chemotherapy and radiotherapy. The study is conducted in elderly patients
with esophagus cancer. Carboplatin is an anticancer chemotherapy drug from alkylating agent category. The study
is estimated to complete by April 2024.
Moreover, in February 2017, Henan Cancer Hospital in collaboration with Jiangsu HengRui Medicine Co., Ltd.,
initiated Phase 2 exploratory clinical trial to evaluate the efficacy of Apatinib, treatment for advanced esophagus
cancer. Apatinib is a tyrosine kinase inhibitor that selectively inhibits the vascular endothelial growth factor
receptor-2(VEGFR2).
However, high cost of therapy for the treatment of gastric and esophageal cancers is expected to restraint the
market growth. For instance, as per the report published in Healthday, in 2013, cancer patients paid US$ 207,000
a year for the treatment and medications while in 1995 the cost was US$ 54,100 a year.
REPORT DESCRIPTION
Gastric and Esophageal Cancer Drugs Market Taxonomy:
By Therapy Type
Chemotherapy
Targeted Therapy
Immunotherapy
By Disease Indication
Adenocarcinomas
Gastrointestinal Stromal Tumors
Carcinoid Tumors
Squamous Cell Carcinoma
Get Request a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/2438
REPORT DESCRIPTION
Gastric and Esophageal Cancer Drugs Market – Key Players











Amgen
Eli Lilly and Company
F. Hoffmann-La Roche
Bristol-Myers Squibb Company
Boehringer Ingelheim GmbH
Bristol-Myers Squibb
GlaxoSmithKline Plc
Novartis AG
Johnson & Johnson
Gilead Sciences
Merck & Co
Get More Inf @ https://www.coherentmarketinsights.com/ongoing-insight/gastric-and-esophageal-cancer-drugs-market-2438
ABOUT COHERENT MARKET INSIGHTS
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its
plethora of clients achieve transformational growth by helping them make critical business decisions. We are
headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players
from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help
businesses around the globe deliver practical and lasting results through various recommendations about
operational improvements, technologies, emerging market trends and new working methods. We offer both
customized and syndicated market research reports that help our clients create visionary growth plans to
provide traction to their business. We meticulously study emerging trends across various industries at both the
global and regional levels to identify new opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
MARKET INTELLIGENCE SERVICES
CUSTOMIZED RESEARCH
CONSULT STUDIES
SYNDICATED RESEARCH
COUNTRY SPECIFIC STUDIES
ABOUT CMI
SECTOR
COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS







Global Leading Equipment and System Manufacturers
Component Providers and System Integrators
Distributors, Retailors and Value Added Resellers
Healthcare IT Solutions Developers
Marketing Consultancies and the Advertising Industry
Private and Government organization
Outsourcing Companies
ABOUT US
KEY STATS
RESEARCH
SOLUTIONS
FEASIBILITY
STUDIES
GLOBAL
REPORTS
100+
Insights Published Per Year
150+
Consulting Projects Till Date
125+
Clients Worldwide Per Year
110+
COUNTRY
ANALYSIS
CONSULT
PROJECTS
SURVEY
RESEARCH
EXCEL
FORECAST
DATABASE
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare,
and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports
across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique
—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our
clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities
posed therein.
THANK YOU
To know more about us, visit our website:
www.coherentmarketinsights.com
For sales queries or new topics email us on:
[email protected]
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
[email protected]
+1-206-701-6702
1/--pages
Report inappropriate content